274 results on '"Potthoff, Sebastian"'
Search Results
52. Evaluating Implementation Contexts, Mechanisms, and Outcomes: A Normalization Process Theory Coding Manual for Qualitative Research and Instrument Development
53. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
54. Enhancing the translation of health behaviour change research into practice:A selective conceptual review of the synergy between implementation science and health psychology
55. White Paper: Open Digital Health – accelerating transparent and scalable health promotion and treatment
56. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
57. IMMUNE CELLS MEDIATED EFFECTS OF SODIUM CHLORIDE ON THE DEVELOPMENT OF VASCULAR INFLAMMATION AND ABDOMINAL AORTIC ANEURYSM IN ANGIOTENSIN II-TREATED APOE-KO MICE
58. Enhancing the translation of health behaviour change research into practice: a selective conceptual review of the synergy between implementation science and health psychology
59. Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
60. ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
61. Role of α2-Adrenoceptors in Hypertension: Focus on Renal Sympathetic Neurotransmitter Release, Inflammation, and Sodium Homeostasis
62. Protective effects of PPARγ agonist in acute nephrotic syndrome
63. Prorenin Receptor Is Essential for Podocyte Autophagy and Survival
64. Regulation of renal sympathetic neurotransmission by renal α2A-adrenoceptors is impaired in chronic renal failure
65. α2A-Adrenoceptors Modulate Renal Sympathetic Neurotransmission and Protect against Hypertensive Kidney Disease
66. Using practical health psychology approaches in your rheumatology practice
67. Additional file 1: of Exploring the role of competing demands and routines during the implementation of a self-management tool for type 2 diabetes: a theory-based qualitative interview study
68. Additional file 3: of Exploring the role of competing demands and routines during the implementation of a self-management tool for type 2 diabetes: a theory-based qualitative interview study
69. Additional file 2: of Exploring the role of competing demands and routines during the implementation of a self-management tool for type 2 diabetes: a theory-based qualitative interview study
70. Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
71. Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
72. The relationship between habit and healthcare professional behaviour in clinical practice: a systematic review and meta-analysis
73. Inhibition of MAPK P38 Decreases Hyperglycemia-Induced Nephrin Endocytosis and Protects Against Proteinuria
74. Force spectroscopic detection of peptide cleavage by thrombin exploiting biotin–streptavidin interactions in a bio-sensing context
75. Planning to be routine: habit as a mediator of the planning-behaviour relationship in healthcare professionals
76. Additional file 2: of Planning to be routine: habit as a mediator of the planning-behaviour relationship in healthcare professionals
77. Additional file 1: of Planning to be routine: habit as a mediator of the planning-behaviour relationship in healthcare professionals
78. Molecular Dynamics Simulations of the Silica–Cell Membrane Interaction: Insights on Biomineralization and Nanotoxicity
79. Additional file 2: Table S2. of Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
80. Additional file 1: Table S1. of Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
81. A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease
82. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction
83. Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis
84. Additional file 1: Table S1. of The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
85. Implementation intention and planning interventions in Health Psychology: Recommendations from the Synergy Expert Group for research and practice
86. Implementation intention and planning interventions in Health Psychology: Recommendations from the Synergy Expert Group for research and practice
87. Novel Approaches in Hypertension Treatment - Modulation of the Sympathetic Overactivity
88. Abstract 062: Inhibition of Phosphodiesterase 5 Attenuates Angiotensin II Dependent Hypertension and Renal Vascular Dysfunction in C57BL/6 but Not in eNOS-KO Mice
89. High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification
90. Differentielle Proteomanalyse der Niere mittels 2D-Gelelektrophorese und Untersuchung des glomerulären Proteoms in einem Mausmodell der chronischen Niereninsuffizienz
91. Implementation intentions for creating and breaking habits in care provided to patients with type 2 diabetes: a dual process approach
92. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
93. Abstract 348: Inhibition Of Phosphodiesterase 5 Attenuates Angiotensin II-dependent Hypertension And Renal Vascular Dysfunction In C57bl/6 Mice But Not In Enos-Ko Mice
94. Angiotensin-(1–7) Modulates Renal Vascular Resistance Through Inhibition of p38 Mitogen-Activated Protein Kinase in Apolipoprotein E–Deficient Mice
95. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
96. Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension
97. Renale Denervation
98. The “resistant hypertension team”: focus on a multidisciplinary approach to hypertension
99. P2Y2 receptor deficiency aggravates chronic kidney disease progression
100. Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.